Quick Answer
Coherus Oncology, Inc. reported Net Income of $168.02 million for fiscal year 2025.
Coherus Oncology, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $168.02M | +489.4% |
| 2024 | $28.51M | +112.0% |
| 2023 | -$237.89M | +18.5% |
| 2022 | -$291.75M | -1.6% |
| 2021 | -$287.10M | -317.1% |
| 2020 | $132.24M | +47.2% |
| 2019 | $89.83M | +142.9% |
| 2018 | -$209.34M | +12.1% |
| 2017 | -$238.17M | -87.0% |
| 2016 | -$127.34M | +43.0% |
| 2015 | -$223.26M | -156.2% |
| 2014 | -$87.13M | -62.5% |
| 2013 | -$53.63M | -62.4% |
| 2012 | -$33.02M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$35.53M | -230.5% | -111.9% |
| June 30, 2025 | $297.77M | +2404.5% | +626.4% |
| March 31, 2025 | -$56.57M | -155.0% | -426.2% |
| September 30, 2024 | -$10.75M | +72.9% | +16.8% |
| June 30, 2024 | -$12.92M | +69.9% | -112.6% |
| March 31, 2024 | $102.88M | +235.8% | +359.5% |
| September 30, 2023 | -$39.64M | +54.3% | +7.5% |
| June 30, 2023 | -$42.87M | +14.5% | +43.4% |
- Coherus Oncology, Inc. showed an increase of +489.4% in Net Income compared to the prior fiscal year.
- Over the 2012–2025 period, Coherus Oncology, Inc.’s net income has grown by 608.9% (from -$33.02 million to $168.02 million).
- The most recent figure is from Coherus Oncology, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 9, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: